Company News, Financial News

Johnson & Johnson Reports Fourth-Quarter Sales of $24.8 Billion in 2021

Consumer Health worldwide adjusted operational sales increased 3.8%, primarily driven by over-the-counter products, Neutrogena and Aveeno products.

Author Image

By: Lianna Albrizio

Associate Editor

Johnson & Johnson today reported sales of $24.8 billion in the fourth quarter, reflecting a growth of 10.4%.     Full-year sales for 2021 were $93.8 billion, or a 13.6% growth.   “Our 2021 performance reflects continued strength across all segments of our business,” said Joaquin Duato, chief executive officer at Johnson & Johnson. “Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters